AGFA-GEVAERT NV (AGFB.BR)
BE0003755692 - Common Stock
Taking everything into account, AGFB scores 2 out of 10 in our fundamental rating. AGFB was compared to 12 industry peers in the Health Care Technology industry. The financial health of AGFB is average, but there are quite some concerns on its profitability. AGFB has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year AGFB has reported negative net income.
In the past year AGFB has reported a negative cash flow from operations.
AGFB had negative earnings in 4 of the past 5 years.
AGFB had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.61%, AGFB is doing worse than 75.00% of the companies in the same industry.
With a Return On Equity value of -9.76%, AGFB is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
AGFB has a Return On Invested Capital of 0.29%. This is in the lower half of the industry: AGFB underperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.61% | ||
| ROE | -9.76% | ||
| ROIC | 0.29% |
ROA(3y)-6.95%
ROA(5y)0.93%
ROE(3y)-23.67%
ROE(5y)-5.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of AGFB (0.35%) is worse than 75.00% of its industry peers.
AGFB's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 31.53%, AGFB is doing worse than 83.33% of the companies in the same industry.
AGFB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.35% | ||
| PM (TTM) | N/A | ||
| GM | 31.53% |
OM growth 3Y-17.71%
OM growth 5Y-24.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.5%
GM growth 5Y-0.57%
2. Health
2.1 Basic Checks
AGFB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AGFB remains at a similar level compared to 1 year ago.
The number of shares outstanding for AGFB has been reduced compared to 5 years ago.
Compared to 1 year ago, AGFB has a worse debt to assets ratio.
2.2 Solvency
AGFB has an Altman-Z score of 2.15. This is not the best score and indicates that AGFB is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.15, AGFB perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 0.40 indicates that AGFB is not too dependend on debt financing.
The Debt to Equity ratio of AGFB (0.40) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.15 |
ROIC/WACC0.03
WACC9.83%
2.3 Liquidity
A Current Ratio of 2.14 indicates that AGFB has no problem at all paying its short term obligations.
AGFB has a Current ratio (2.14) which is comparable to the rest of the industry.
A Quick Ratio of 1.24 indicates that AGFB should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.24, AGFB perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.14 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
AGFB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.23%, which is quite impressive.
The Revenue for AGFB has decreased by -25.77% in the past year. This is quite bad
Measured over the past years, AGFB shows a very negative growth in Revenue. The Revenue has been decreasing by -12.10% on average per year.
EPS 1Y (TTM)54.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-25.77%
Revenue growth 3Y-12.37%
Revenue growth 5Y-12.1%
Sales Q2Q%-0.35%
3.2 Future
Based on estimates for the next years, AGFB will show a very strong growth in Earnings Per Share. The EPS will grow by 29.78% on average per year.
AGFB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.10% yearly.
EPS Next Y81.42%
EPS Next 2Y40.26%
EPS Next 3Y29.78%
EPS Next 5YN/A
Revenue Next Year1.3%
Revenue Next 2Y2.69%
Revenue Next 3Y3.1%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AGFB. In the last year negative earnings were reported.
Also next year AGFB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
AGFB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AGFB is cheaper than 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.38 |
4.3 Compensation for Growth
A more expensive valuation may be justified as AGFB's earnings are expected to grow with 29.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.26%
EPS Next 3Y29.78%
5. Dividend
5.1 Amount
No dividends for AGFB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AGFA-GEVAERT NV
EBR:AGFB (12/24/2024, 7:00:00 PM)
0.689
+0 (+0.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners55.01%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap106.67M
Analysts74
Price Target1.35 (95.94%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)22.97%
Min EPS beat(2)-96.08%
Max EPS beat(2)142.02%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.02%
Min Revenue beat(2)-11.52%
Max Revenue beat(2)-4.53%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.36%
PT rev (3m)-18.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)17.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.09 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.28 | ||
| P/tB | 0.78 | ||
| EV/EBITDA | 4.38 |
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS7.29
BVpS2.45
TBVpS0.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.61% | ||
| ROE | -9.76% | ||
| ROCE | 0.39% | ||
| ROIC | 0.29% | ||
| ROICexc | 0.31% | ||
| ROICexgc | 0.41% | ||
| OM | 0.35% | ||
| PM (TTM) | N/A | ||
| GM | 31.53% | ||
| FCFM | N/A |
ROA(3y)-6.95%
ROA(5y)0.93%
ROE(3y)-23.67%
ROE(5y)-5.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-23.56%
ROICexcg growth 5Y-30.85%
ROICexc growth 3Y-23.57%
ROICexc growth 5Y-27.42%
OM growth 3Y-17.71%
OM growth 5Y-24.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.5%
GM growth 5Y-0.57%
F-Score4
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.26 | ||
| Cap/Depr | 95.35% | ||
| Cap/Sales | 3.63% | ||
| Interest Coverage | 0.25 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.14 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 2.15 |
F-Score4
WACC9.83%
ROIC/WACC0.03
Cap/Depr(3y)56.62%
Cap/Depr(5y)51.62%
Cap/Sales(3y)2.44%
Cap/Sales(5y)2.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y81.42%
EPS Next 2Y40.26%
EPS Next 3Y29.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-25.77%
Revenue growth 3Y-12.37%
Revenue growth 5Y-12.1%
Sales Q2Q%-0.35%
Revenue Next Year1.3%
Revenue Next 2Y2.69%
Revenue Next 3Y3.1%
Revenue Next 5YN/A
EBIT growth 1Y102.33%
EBIT growth 3Y-27.89%
EBIT growth 5Y-34.02%
EBIT Next Year241.58%
EBIT Next 3Y70.84%
EBIT Next 5YN/A
FCF growth 1Y61.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y97.7%
OCF growth 3YN/A
OCF growth 5YN/A